Standard Life Aberdeen plc decreased its stake in Amdocs Limited (NASDAQ:DOX) by 10.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,492,964 shares of the technology company’s stock after selling 301,213 shares during the period. Standard Life Aberdeen plc’s holdings in Amdocs were worth $163,252,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently modified their holdings of the company. American International Group Inc. acquired a new stake in shares of Amdocs in the fourth quarter valued at about $199,000. CENTRAL TRUST Co increased its stake in shares of Amdocs by 45.0% in the fourth quarter. CENTRAL TRUST Co now owns 3,388 shares of the technology company’s stock valued at $222,000 after buying an additional 1,052 shares during the period. Cerebellum GP LLC acquired a new stake in shares of Amdocs in the fourth quarter valued at about $246,000. Raymond James Financial Services Advisors Inc. acquired a new stake in shares of Amdocs in the second quarter valued at about $279,000. Finally, Blue Sky Asset Management LLC acquired a new stake in shares of Amdocs in the fourth quarter valued at about $314,000. 91.66% of the stock is owned by institutional investors.
Several brokerages have recently weighed in on DOX. Stifel Nicolaus increased their price target on Amdocs from $72.00 to $75.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Oppenheimer reissued a “buy” rating and issued a $77.00 price target on shares of Amdocs in a research note on Wednesday, January 31st. BidaskClub cut Amdocs from a “sell” rating to a “strong sell” rating in a research note on Tuesday, December 5th. Finally, Zacks Investment Research cut Amdocs from a “buy” rating to a “hold” rating in a research note on Monday, November 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $70.71.
Shares of Amdocs Limited (NASDAQ DOX) opened at $65.76 on Thursday. Amdocs Limited has a one year low of $59.30 and a one year high of $71.37. The company has a market capitalization of $9,510.38, a P/E ratio of 21.21, a P/E/G ratio of 2.26 and a beta of 0.52.
Amdocs (NASDAQ:DOX) last released its earnings results on Tuesday, January 30th. The technology company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.89 by $0.17. Amdocs had a return on equity of 15.13% and a net margin of 11.72%. The business had revenue of $977.70 million during the quarter, compared to analysts’ expectations of $979.13 million. During the same quarter last year, the firm posted $0.90 earnings per share. The firm’s revenue was up 2.4% on a year-over-year basis. equities research analysts predict that Amdocs Limited will post 3.75 earnings per share for the current fiscal year.
Amdocs announced that its board has approved a stock repurchase program on Wednesday, November 8th that allows the company to buyback $800.00 million in shares. This buyback authorization allows the technology company to reacquire shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 20th. Investors of record on Friday, March 30th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $1.00 annualized dividend and a yield of 1.52%. This is a boost from Amdocs’s previous quarterly dividend of $0.22. Amdocs’s dividend payout ratio (DPR) is currently 28.39%.
COPYRIGHT VIOLATION WARNING: This article was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/22/standard-life-aberdeen-plc-sells-301213-shares-of-amdocs-limited-dox.html.
Amdocs Company Profile
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.